Last Friday, President Trump, with the help of Health and Human Services Secretary Alex Azar, unveiled the administration’s “Blueprint to Lower Drug Prices.” As this issue was a central tenet of President Trump’s 2016 campaign platform, guidance on the administration’s approach to tackling drug prices has long been anticipated.
Prescription drugs have long been one of the greatest plagues on the country’s healthcare costs. While this issue has garnered attention for decades, the drug debate has a renewed vigor in Washington since President Trump unveiled his “Blueprint to Lower Drug Prices” last week.
The goals of the four maternal care designation levels are to improve maternal and newborn outcomes and reduce healthcare costs. How do you prepare for the changes?
Teaching hospitals across the United States spend an estimated $17 billion annually on graduate medical education (GME) programs. While federal and state funding provides some offsetting revenue, teaching hospitals and academic health systems must make a significant investment in training new physicians each year.
For those acute care hospitals and physician group practices that submitted applications, there are three key areas to focus efforts in the coming months to prepare for BPCI Advanced: Analyze, Prioritize and Operationalize.
Why have medical schools become more dependent on funding from teaching hospitals? Because all other funding sources have flattened or declined, while maintaining competitive academic programs has only become more expensive.
On January 1, the 2018 final rule regarding payment for Medicare services under the Hospital Outpatient Prospective Payment System went into effect. The Centers for Medicare & Medicaid Services (CMS) removed knee replacements from the inpatient-only list and defined an outpatient hospital reimbursement rate for these cases.
Recent changes to CMS’s Hospital Outpatient Prospective Payment System (OPPS) rule for CY 2018 have created a stir across the healthcare industry due to the profound impact on organizations participating in the 340B Drug Pricing Program.
CMS has finalized the CY 2018 Hospital Outpatient Prospective Payment System (OPPS) rule, confirming changes to the 340B Drug Pricing Program that were proposed earlier this year.
Page 1 of 7